Gensia Splits Up
Executive Summary
Gensia has long been a model of a discovery-stage biotech, funding its research and simultaneously building a market presence through acquiring and marketing a suite of low-margin niche therapeutics with the intention of adding its own, internally-developed drugs to its product mix later on.